NOVO — December 2025
-
Nyheder fra danske medier med Novo Nordisk, Ambu og Pandora https://proinvestor.com/investornyt/1389447/nyheder-fra-danske-medier-med-novo-nordisk-ambu-og-pandora
-
-
Novo Nordisk er ikke klar til opgive Alzheimers trods tilbagesalg https://proinvestor.com/investornyt/1389478/novo-nordisk-er-ikke-klar-til-opgive-alzheimers-trods-tilbagesalg
-
I kølvandet på regnskaberne kommer der ofte en periode i limbo, hvor investorerne afventer nogle begivenheder, der kan sætte skub i tingene. Og det er situationen lige nu. Sprænger AI-boblen i USA? Kommer der en rentenedsættelse her i december? Og så giver Helge Larsen en kort update på Alzheimer-medicin fra både Anavex og Novo Nordisk.
Kort video: https://proinvestor.com/boards/130131/
-
Nyheder fra danske medier med Novo Nordisk og Coloplast https://proinvestor.com/investornyt/1389933/nyheder-fra-danske-medier-med-novo-nordisk-og-coloplast
-
'
Novo Nordisk A/S (NVO): A Bull Case Theory https://finance.yahoo.com/news/novo-nordisk-nvo-bull-case-152940906.html -
Novo-finansdirektør vil fokusere på lancering af Wegovy-pille i USA https://proinvestor.com/investornyt/1389957/novo-finansdirektor-vil-fokusere-pa-lancering-af-wegovy-pille-i-usa
-
Novo Nordisk (NYSE:NVO) Embodies Quality Investing Principles https://www.chartmill.com/news/NVO/Chartmill-38660-Novo-Nordisk-NYSENVO-Embodies-Quality-Investing-Principles
-
Sammenhæng mellem fedme og Altheimers i nyt amerikansk studie:
https://www.msn.com/da-dk/nyheder/other/nyt-studie-peger-på-sammenhæng-mellem-overvægt-og-hurtigere-alzheimer-udvikling/ar-AA1RMChx?ocid=msedgdhp&pc=U531&cvid=6934775a1b3d43668eedc336ece151a8&ei=5 -
Novo Nordisk: Når Wegovy pillen er godkendt... https://proinvestor.com/boards/130193
-
Novo tester nyt middel på otteårige: Eksperter betegner det som et »tricky« dilemma
Novo Nordisk vil teste sin nye vægttabsmedicin på børn ned til otte år. Men det er en etisk balancegang, advarer eksperter.
Finans (finans.dk)
-
Mulig Novo-konkurrent i vild kursstigning efter opløftende vægttabsdata for fedmepille https://proinvestor.com/investornyt/1391042/mulig-novo-konkurrent-i-vild-kursstigning-efter-oploftende-vaegttabsdata-for-fedmepille
-
Bog: Den ultimative introduktion til Novo Nordisk https://proinvestor.com/boards/130210
-
Deep Value Investing
@DeepIceValue$NVO has slashed Wegovy prices in India nearly 40%. This move has dramatically increased sales volume by 70% in November. The drug's market share also rose 14%.
This price reduction aims to compete with rival Mounjaro..
Another $NVO drug, Ozempic, is expected to launch soon, potentially further impacting the prices..
-
Novo Nordisk has completed its acquisition of Akero Therapeutics https://ml-eu.globenewswire.com/Resource/Download/ef5d46b2-5731-42ce-9ac9-8dc2c75ffc26
-
Novo Nordisk overtager endeligt Akero https://proinvestor.com/investornyt/1391512/novo-nordisk-overtager-endeligt-akero
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind